lamotrigine has been researched along with Central Nervous System Diseases in 5 studies
Central Nervous System Diseases: Diseases of any component of the brain (including the cerebral hemispheres, diencephalon, brain stem, and cerebellum) or the spinal cord.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Clozapine treatment remains the gold standard for treatment-resistant schizophrenia, but treatment with clozapine is associated with several side-effects that complicate the use of the drug." | 4.87 | Optimizing clozapine treatment. ( Damkier, P; Lublin, H; Nielsen, J; Taylor, D, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (40.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Vukojević, Z | 1 |
| Ilić, TV | 1 |
| Dominović-Kovačević, A | 1 |
| Grgić, S | 1 |
| Mavija, S | 1 |
| Nielsen, J | 1 |
| Damkier, P | 1 |
| Lublin, H | 1 |
| Taylor, D | 1 |
| Meldrum, BS | 1 |
| Canavero, S | 1 |
| Bonicalzi, V | 1 |
| Alao, AO | 1 |
| Dewan, MJ | 1 |
2 reviews available for lamotrigine and Central Nervous System Diseases
| Article | Year |
|---|---|
Optimizing clozapine treatment.
Topics: Antipsychotic Agents; Calcium Channel Blockers; Central Nervous System Diseases; Clozapine; Combined | 2011 |
The role of glutamate in epilepsy and other CNS disorders.
Topics: Animals; Central Nervous System Diseases; Epilepsy; Glutamic Acid; Humans; Lamotrigine; Mice; N-Meth | 1994 |
3 other studies available for lamotrigine and Central Nervous System Diseases
| Article | Year |
|---|---|
Neurosarcoidosis and multiple intracerebral hematomas: An unusual clinical presentation.
Topics: Anti-Inflammatory Agents; Anticonvulsants; Central Nervous System Diseases; Cerebral Hemorrhage; Fem | 2017 |
Lamotrigine control of central pain.
Topics: Adult; Aged; Aged, 80 and over; Analgesics; Anticonvulsants; Central Nervous System Diseases; Female | 1996 |
Evaluating the tolerability of the newer mood stabilizers.
Topics: Acetates; Amines; Anticonvulsants; Bipolar Disorder; Central Nervous System Diseases; Cyclohexanecar | 2001 |